Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Sangamo HIV drug

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by undcvr, Feb 28, 2011.

  1. undcvr

    undcvr Senior Member

    Messages:
    818
    Likes:
    182
    NYC
  2. SpecialK82

    SpecialK82 Ohio, USA

    Messages:
    992
    Likes:
    818
    Ohio, USA
    It sounds great, it protects part of the immune system from HIV so that the immune system can work against the virus, and patients wouldn't have to take ARV's anymore, he said it would be a functional cure. Unfortunately, only in Phase 1 clinical trials and said it can take a long time to come to market.

    Thanks for posting!
     
  3. Navid

    Navid Senior Member

    Messages:
    451
    Likes:
    234
    how do you get a company like this to look at me/cfs blood/tissue too.....many of us have the same opportunistic infections as an hiv patient...we just don't die as fast.
     

See more popular forum discussions.

Share This Page